Ketoreductase-catalyzed dynamic reductive kinetic resolution of sterically hindered 2-aryl-1,5-benzothiazepin-3,4(2 H ,5 H )-diones: asymmetric synthesis of a key diltiazem precursor and its analogues
Green Chemistry · 2024 · 26 (13) · 7818-7824
DOI: 10.1039/d4gc01478b ↗Kurz gefasst
Fachartikel in der Zeitschrift Green Chemistry, 2024. Verfasst von Zijun Guo und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Basic Research Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
An efficient, green, and stereoselective synthesis of cis -(2 S ,3 S )-2,3-dihydro-3-hydroxy-2-aryl-1,5-benzothiazepin-4(5 H )-ones was developed via ketoreductase-catalyzed dynamic reductive kinetic resolution.
Förderung
- National Basic Research Program of China
- National Natural Science Foundation of China
Zitieren
APA
Guo, Z., Wu, Z., Wu, X., Zhang, L., Huang, Z., & Chen, F. (2024). Ketoreductase-catalyzed dynamic reductive kinetic resolution of sterically hindered 2-aryl-1,5-benzothiazepin-3,4(2 H ,5 H )-diones: asymmetric synthesis of a key diltiazem precursor and its analogues. Green Chemistry, 26(13), 7818-7824. https://doi.org/10.1039/d4gc01478b
Vancouver
Guo Z, Wu Z, Wu X, Zhang L, Huang Z, Chen F. Ketoreductase-catalyzed dynamic reductive kinetic resolution of sterically hindered 2-aryl-1,5-benzothiazepin-3,4(2 H ,5 H )-diones: asymmetric synthesis of a key diltiazem precursor and its analogues. Green Chemistry. 2024;26(13):7818-7824. doi:10.1039/d4gc01478b
BibTeX
@article{Guo2024,
author = {Guo, Zijun and Wu, Zexin and Wu, Xiaofan and Zhang, Li and Huang, Zedu and Chen, Fener},
title = {Ketoreductase-catalyzed dynamic reductive kinetic resolution of sterically hindered 2-aryl-1,5-benzothiazepin-3,4(2 H ,5 H )-diones: asymmetric synthesis of a key diltiazem precursor and its analogues},
journal = {Green Chemistry},
year = {2024},
volume = {26},
number = {13},
pages = {7818--7824},
doi = {10.1039/d4gc01478b}
}
EUVIMED